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Isoniazid is a key antitubercular agent which exhibits poor chemical stability in the solid 
state. Cocrystallization with hydroxyl derivatives of cinnamic acid, which themselves 
possesses antitubercular and antioxidant activity, may produce solid forms with improved 
pharmaceutical properties. The complementary nature of the functional groups of isoniazid 
and the chosen coformers resulted in a high success rate for cocrystal formation. The three 
previously unknown cocrystal forms, plus a new polymorph were characterized by solid-state 
NMR, DSC, PXRD and single crystal XRD. Three previously known cocrystals were also 
synthesized and characterized. NMR chemical shifts were observed to distinguish between a 
key synthon involving the carboxylic acid of cinnamic acid. 
Introduction 
The World Health Organization (WHO) has declared tuberculosis (TB) to be a global 
emergency. Treatment of TB with a single drug in isolation, however, is associated with risks 
of drug resistance, and the International Union against TB and Lung Diseases has 
recommended the use of fixed-dose combinations (FDCs) of first line anti-TB drugs to 
prevent monotherapy and drug resistance.[1],[2] Isoniazid (INH), a highly active drug 
recommended by WHO against M. tuberculosis, is being used as the primary constituent of 
different FDCs and “triple therapies” to combat tuberculosis since 1952.[3] Having good 
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solubility and stability[4] there are, however, conerns about the stability of FDCs involving 
INH and rifampicin (RIF), another antitubercular antibiotic; RIF exhibits significantly 
impaired bioavailability in FDC dosage forms when compared to formulations containing 
only RIF.[5] RIF and INH cross-reaction[6] in the solid formulation environment yields 
isonicotinyl hydrazone under acidic as well as basic conditions on storage of solid FDC 
formulations under accelerated stability test conditions.[7] Moisture absorbance by tablet 
INH and ethambutol was also observed under accelerat d stability test conditions.[8] These 
interactions lead to decreased stability of the FDCs.  
 
Oxidative stress is considered responsible for the hepatotoxicity in the TB patients when 
administered with anti-TB drugs like INH, RIF and pyrazinamide.[9] Treatment with 
antioxidants like curcumin, silymarin and N-acetyl cysteine have shown hepato-protective 
results.[9] This suggest a potential adjuvant role f antioxidant drugs[10] when combined 
with anti-TB treatments.[11] Oxidation reactions are also one of the main causes of 
degradation of Active pharmaceutical ingridients (APIs) or tablets. Hence cocrystallization 
with antioxidants may reduce oxidative stress in tuberculosis patients during treatment and 
may increase the shelf-life of FDCs.  
 
Natural products bearing the cinnamoyl moiety have ttracted much attention due to their 
broad spectrum of biological activities and low toxicity. Trans-cinnamic acid derivatives have 
shown to augment the activity of various antibiotics against Mycobacterium avium[12] and 
also show antioxidant, anti-inflammatory and cytotoxic properties.[13],[14] Cinnamic acid 
derivatives bearing phenolic hydroxyl groups also have free radical scavenging 
properties[15],[16], and so may sacrificially reduce the chemical degradation of easily 
oxidized APIs, such as INH. Weakly basic drugs show decreased solubility and dissolution as 
pH increases from 1 to 7 along the gastrointestinal tract, which is detrimental to drug 
absorption. Cocrystallization of basic drugs, such as INH, with acidic coformers can mitigate 
these effects.[17] Moreover, the degradation of RIFand INH due to hydrazone formation in 
FDC may potentially be countered by masking the hydrazi e group through cocrystallization, 
as well as allowing INH to be combined with an antioxidant in a single tablet. In this present 
study, hydroxyl derivatives of cinnamic acid were employed to synthesize new cocrystal 
forms of INH (Scheme 1). 
 
Crystal engineering provides an opportunity to develop new solid forms based on non-
covalent intermolecular forces interactions among components[18], and pharmaceutical 
cocrystallization[19],[20],[21],[22],[23] is being widely investigated as a strategy to improve 
the physicochemical and stability properties of solid dosage forms of APIs.[24],[25],[26] 
Formulation of two or more APIs having complementary functional groups into a single 
dosage can save manufacturing, packaging and storage resources as well as being provide 
convenient to patients. As an example, sildenafil-acetylsalicylic acid cocrystal has improved 
physiochemical properties with higher dissolution rates compared to the marketed form,of 
sildenafil citrate.[27] One approach to understand cocrystals structures is to identify sub 
structural units, commonly termed “supramolecular synthons”.[28] For example, the synthon 
formed between the N of pyridine and the hydroxyl of carboxylic acid has been previously 
used to design cocrystals of INH.[29],[30] Hydroxyl derivatives  of cinnamic acid provide 
potentially additional opportunities for hydrogen bonding with INH.[31]  
 
Solid-state NMR is frequently used to characterize cocrystals, particularly when they have 
been produced by mechanical grinding and so single-crystal diffraction is not possible.[32], 
[33],[34] NMR chemical shifts are sensitive to local chemical environments, and so, for 
example, can distinguish between cases where a hydrogen has been transferred between API 
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and coformer to generate a salt form. Moreover, advances in quantum chemistry mean that 
chemical shifts can now be calculated with good precision given a crystal structure, allowing 
correlations between structure and solid-state NMR shifts to be investigated, for example, on 




Scheme 1: Chemical structures and abbreviated names used for molecules used in this study: 
isoniazid (INH), cinnamic acid (CINN), 2-hydroxycinnamic acid (2HCA), 3-
hydroxycinnamic acid (3HCA), 4-hydroxycinnamic acid (4HCA), 2,4-dihydroxycinnamic 
acid (24HCA) and 3,4-dihydroxycinnamic acid (34DHCA). The 34DHCA molecule adopts 
the conformation shown in most of the structures obtained but adopts a conformation with a 
180° rotation about the bond indicated with asterisks n one of the forms. 
Experimental 
Synthesis of Cocrystals  
Isoniazid and coformers were purchased from Sigma-Aldrich and used without further 
purification. All samples analyzed were produced by cr stallization. In the case of 4HCA, 
3HCA and 2HCA coformers, crystalline samples of the cocrystals with INH were obtained 
directly by dissolving 1:1 molar ratio of coformer and INH separately in methanol. The 
solutions were mixed and heated at 55 °C for 30 mins with stirring and left at room 
temperature. Slow evaporation led to the formation of colored crystals after some days, which 
were filtered out.  
 
CINN, 24DHCA and 34DHCA failed to form cocrystals via this route, but crystalline 
samples were obtained by recrystallization of powder materials produced by liquid assisted 
grinding (it is plausible that microscopic crystals produced by grinding acted as seed crystals 
in the subsequent crystallization step). Except for INH-CINN, where a 2:1 mixture of 
ethanol/acetonitrile was used as the solvent, the raw grinding product was obtained by 
methanol-assisted grinding of a 1:1 stochiometric ratio for 35 mins. Final crystalline products 
were then obtained by slow evaporation of the ground product using the same solvent used 
for liquid-assisted grinding. The product in the case of 34DHCA was not fully reproducible; 
recrystallization of the grinding material obtained after 35 mins generally produced a new co-
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crystal polymorph (designated Form 4), while the recrystallization of the product after longer 
grinding (about 50 minutes) generally produced a mixture of forms, partly Form 4, but also 
some Form 1 (as identified by single-crystal XRD). This complex polymorphic behavior was 
not investigated further. 
 
Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) experiments were performed on Perkin Elmer DSC 
8500 running from 30 to 350 °C at 10 °C per minute in a standard aluminum pan in an inert 
atmosphere (helium). All the samples had decomposed by 350 oC and so only the first heating 
run is shown. The Pyris software (version 13) was used to remove baseline gradients before 
plotting and determination of transition temperatures. 
 
Solid-State NMR Spectroscopy  
Solid-state 13C NMR spectra were obtained on a Bruker Avance III HD spectrometer using a 
13C resonance frequency of 125.7 MHz (magnetic field strength of 11.7 T). Approximately 
100 mg of crystalline sample was packed into a zirconia 4 mm rotor with a Kel-F cap. The 
cross-polarization magic angle spinning (CP-MAS) pulse sequence was used for spectral 
acquisition at a spinning rate of 10.00 kHz, with the magic angle setting calibrated using KBr. 
Spectra were obtained using a recycle delay of 180 seconds and number of scans was 320 for 
cocrystals, while the corresponding parameters for INH were 600 seconds and 120 scans 
respectively. Data sets were Fourier transformed with a 5 Hz line broadening and phase 
corrected to produce a frequency domain spectrum. The chemical shifts were referenced 
indirectly to neat tetramethylsilane by setting the high frequency signal of adamantane to 38.5 
ppm. 1H NMR spectra were also obtained under fast MAS conditions. These exhibited some 
unusual features which will be explored in a separate publication; see the Supplementary 
Information (SI) figure S19. 
 
X-Ray Crystallography 
Powder X-ray diffraction measurements were performed on a Bruker D8 Advance 
diffractometer equipped with Cu Kα1,2 source (λ = 1.5418 Å), Lynx-eye Soller PSD detector 
and variable slits. The samples produced by crystallization were lightly ground and sprinkled 
onto Si slides covered with a thin layer of Vaselin. Each PXRD pattern was collected at 
room temperature for 30 minutes over a 2θ range of 3–55° using a step size of 0.02°.  
 
The X-ray single crystal data were collected at 120.0(2) K using Mo Kα radiation (λ  = 
0.71073 Å) on Bruker D8Venture (Photon100 CMOS detector, IμS-microsource, focusing 
mirrors) and Agilent XCalibur (structures INH-4HCA and INH-34DHCA Form 1; Sapphire-3 
CCD detector, fine-focus sealed tube, graphite monochromator) diffractometers equipped 
with the Cryostream (Oxford Cryosystems) open-flow nitrogen cryostats. All structures were 
solved by direct method and refined by full-matrix least squares on F2 for all data using 
Olex2[36] and SHELXTL[37] software. All non-disordered non-hydrogen atoms were 
refined anisotropically. Hydrogen atoms were refined isotropically, except for hydrogen 
atoms not involved in hydrogen bonding in structures INH-4HCA and INH-3HCA, which 
were placed in calculated positions and refined in riding mode. Crystal data and parameters 
of the refinements are listed in Table 2. Crystallographic data for the structures have been 




First principles calculations were carried out using the GIPAW method implemented in 
CASTEP[38], version 17.2. All calculations were performed using the PBE functional[39] 
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and on-the-fly-generated ultrasoft pseudopotentials, with a cut-off energy of 600 eV. All 
atomic positions were geometry optimization with the center of mass and unit-cell parameters 
fixed as their diffraction-determined values, with ntegrals taken over the Brillouin zone 
using a Monkhorst–Pack grid with a maximum k-point sample spacing of 0.1 A–1 and the grid 
origin at k = (¼, ¼, ¼) in fractional reciprocal space. Coordinate input files were generated 
from starting CIF files using CIF2cell[40]. Crystallographically distinct atoms in the output 
magres files[41] are labelled using the labels in the input CIF files. The NMR parameters 
were calculated[42], [43] using the same k-point sampling and cut-off energy. The resulting 
13C shielding values were converted to chemical shift using a reference value of 164.4 ppm 
determined on a subset of 13C resonances that could be unambiguously assigned. 
Results and Discussion 
Cocrystals of INH were synthesized with CINN and its hydroxy derivatives 4HCA, 3HCA, 
2HCA, 24DHCA and 34DHCA. Three cocrystals obtained (INH-4HCA, INH-CINN and 
INH-34DHCA Form 1) have been reported earlier. The INH-4HCA is previously reported by 
Ravikumar,[44] cocrystal INH-CINN corresponds to one of the three polymorphic forms 
reported (Form 4a) by Sarcevica et al.[31],[45] and INH-34DHCA Form 1 was previously 
reported by Swapna et al.[4] All the solid forms were characterized using spectroscopic, 
thermal and X-ray diffraction techniques. IR studies were also performed, but these were 
relatively uninformative, and are presented in SI (figure S1). 
 
DSC Results 
DSC experiments were carried out to study the thermal behavior of the cocrystals in relation 
to isoniazid (melting point 172 °C[23]). The thermal profile of the cocrystals was distinct 
(Figure 1), with transition temperatures distinct from those of the individual components, 
confirming the formation of new solid form. The melting points, calculated from the onset 
values of the single endothermic transition, for INH-4HCA, INH-3HCA and INH-2HCA 
were 174 °C, 165 °C and 172 °C respectively (reported to the nearest oC). INH-CINN shows 
melting point at 133 °C with a minor thermal event at 125 °C (Sarcevica et al.[31] report a 
melting point of 129–132 oC). INH-24DHCA shows two component melt, with onset value of 
146 °C, followed by recrystallization. INH-34DHCA Form 4 has an endothermic peak at 131 
°C, which is likely to be a transformation to Form 1, as the remainder of the curve was a good 




Figure 1: DSC thermogram of the INH cocrystals studied. Figures shown are onset 
temperatures (rounded to nearest oC).  
 
PXRD Results  
In general, the PXRD patterns (Figure 2) are consistent with essentially crystalline products 
and agree well with PXRD patterns calculated from the single crystal studies. For INH-
34DHCA Form 4, the PXRD pattern confirms the formation of essentially crystalline 
product. However, some extra peaks suggest that this product is not pure. The background 
intensity in some PXRD patterns (e.g. INH-CINN) suggests the presence of amorphous or 
poorly crystalline components. For INH-24DHCA, several additional peaks suggest that this 
product is not pure. For INH-2HCA, there are a few extra peaks that indicates a small amount 
of unknown impurities, which is consistent with the NMR results discussed below. In the 
case of INH-CINN, the PXRD pattern is inconsistent with the form (polymorph I) observed 
from the single-crystal study. Instead, the pattern matches that calculated for polymorph II 
reported by Sarcevica et al.[31]. The NMR results below confirm that the sample is mostly 






Figure 2. Experimental (blue) and simulated (black) PXRD patterns of the INH cocrystals 
studied. Calculated patterns were determined from the single crystal XRD structures reported 
herein, except for INH-CINN polymorph II. Additional peaks corresponding to impurity 
phases are indicated by question marks. 
 
 
Single-Crystal XRD Results 
 
The crystal structures of the INH cocrystals were determined by single-crystal X-ray 
crystallography, as summarized in Table 2. The structu es of INH-34DHCA Form 1[4] and 
INH-CINN Form II[31] have been previously reported, but are re-determined and discussed 
here for consistency. Figure 3 shows the labelling scheme and hydrogen bonding between the 
cocrystal components. Detailed views of the crystal packing structures of the cocrystals are 






Figure 3: Atomic labelling and key hydrogen bonding between cocrystal components for the 
different isoniazid cocrystals studied. 
The coformer molecules mostly contain four (five for the dihydroxy derivatives, three for 
CINN) hydrogen atoms capable of forming classical hydrogen bonds and seven (eight for the 
dihydroxy derivatives, six for CINN) possible acceptors. These sites are represented 
schematically in Scheme 2.  
 
Scheme 2: Potential hydrogen bond donor and acceptor sites in the INH cocrystals studied. 
Donor hydrogen sites are labelled with Roman numbers, potential acceptors of hydrogen 




Table 1 lists the hydrogen donors and corresponding acceptors found in the studied 
cocrystals. There are no strong patterns that can be discerned; for any given donor, there are 
at least two possible acceptors. The variety of hydrogen bonding (HB) arrangements means 
that analysis of the structures in terms of supramolecular synthons provides little additional 
insight (see Figure S10 and Table S1 of the SI). Note that some of HBs in Table 1 are quite 
long (for example, III -B in INH-CINN, N...O 3.388 Å) and only their directionality allows 
them to be called hydrogen bonds. The table also indicates whether or not aromatic π...π 
interactions are present. It is notable that these are not always present despite the planarity of 
both components. Graph-set analysis[46] of hydrogen bo d patteren is performed and is 
shown in Figure S11. 
 
Table 1. Hydrogen bonds in the studied INH cocrystals tabulted by donor atom, with donor-
acceptor distances (in Å) shown in parentheses.  
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a Position of hydroxyl group(s) shown in parentheses. 
b Two planar 6-membered aromatic fragments were deemed to be participating in the π…π 
interaction if the centroid-centroid distance between them was less than 4 Å and the shift was 
smaller than 3 Å.31 
 
In contrast to some previous cocrystals involving INH and carboxylic acids[4], the most 
common bonding pattern for carboxylic acids, the centrosymmetrical dimer, was not 
observed in the studied cocrystals. The carboxylic acid hydrogens (I ) only form hydrogen 
bonds with nitrogen atoms (F, amino- or D, pyridino-) and not with carbonyl (A or G). The 
secondary amino-hydrogen atom (II ) is more active than the primary amino hydrogens (III ) 
and forms hydrogen bonds with carbonyl oxygens (A or G). Some potential weaker hydrogen 
bonds from the NH2 group are not formed at all. This contradicts the well-known Etter's first 
rule “All good proton donors and acceptors are used in hydrogen bonding”.[47] 
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In addition to the classical hydrogen bonds the packing motifs are also affected by a number 
of weaker interactions, such as C–H...O bonds. This makes a simple geometrical synthon 
approach inadequate to predict the final crystal packing of the studied systems. However, the 
pair-wise energy-based analysis, which provides an ultimate insight into the crystal packing 
forces, is out of scope of this study. 
 
Perhaps the most surprising result is the discovery of an additional polymorph of INH-
34DHCA. Two crystal structures, plus a third uncharacterized form, have been published to 
date, which were denoted INH-CFA[4]. Careful examination of the structures reported shows 
that the previously reported INH-CFA Form 3 has essentially the same lattice parameters as 
the new INH-34DHCA form but differs in the conformation of 34DHCA (See SI figure S2); 
its conformation differs by 180o rotation around the Ph–C=C bond (as indicated in Scheme 
1). The new form is denoted here as INH-34DHCA Form 4. The different conformations 
adopted are shown in figure S2 (SI).  
 
Table 2. Structure refinement data for the INH cocrystals studied. 
 
Identification code  INH-4HCA  INH-3HCA  INH-2HCA  INH-CINN  INH-24DHCA  INH-34DHCA 
Form 1  
INH-34DHCA 
Form 4 
Empirical formula  C15H15N3O4 C15H15N3O4 C15H15N3O4 C15H15N3O3 C15H15N3O5 C15H15N3O5 C15H15N3O5 
Formula mass / 
g mol–1 
301.30 301.30 301.30 285.30 317.30 317.30 317.30 
Crystal system  monoclinic monoclinic monoclinic triclinic triclinic monoclinic triclinic 
Space group  P21/n P21/n P21/n P-1 P-1 P21/c P-1 
a / Å  7.4152(3) 7.2704(10) 7.5515(4) 7.4080(12) 6.1347(3) 7.2622(3) 7.173(4) 
b / Å  5.70589(16) 5.7811(8) 8.7908(5) 9.4909(15) 7.0980(4) 20.7242(10) 9.505(5) 
c / Å  32.6636(10) 32.257(5) 20.7505(12) 10.1371(16) 16.4732(9) 9.6909(4) 10.884(6) 
α / °  90 90 90 96.849(6) 85.619(6) 90 109.231(17) 
β / °  92.884(3) 91.730(5) 97.614(3) 103.604(6) 82.673(6) 100.998(4) 90.64(2) 
γ / °  90 90 90 101.842(6) 78.468(6) 90 93.174(17) 
Volume / Å3  1380.26(8) 1355.2(3) 1365.35(13) 667.39(19) 696.13(7) 1431.73(11) 699.3(7) 
Z  4 4 4 2 2 4 2 
ρcalc / g cm–3  1.450 1.477 1.466 1.420 1.514 1.472 1.507 
μ / mm–1  0.107 0.109 0.109 0.101 0.116 0.113 0.115 
F(000)  632.0 632.0 632.0 300.0 332.0 664.0 332.0 
Refl. collected  23361 21214 21314 12030 12496 19007 9065 
Independent refl.,  
Rint  
3673, 0.0401 3276, 0.0825 3802, 0.0549 2912, 0.0994 3182, 0.0873 3793, 0.0819 3387, 0.0456 
Data/restraints/pa
rameters  
3673/0/219 3276/0/219 3802/0/259 2912/0/250 3182/0/268 3793/0/268 3387/0/268 
Goodness-of-fit on 
F2  
1.026 1.060 1.011 0.951 0.954 1.027 0.974 
Final R1 indexes [I 
≥ 2σ (I)]  
0.0413 0.0534 0.0461 0.0588 0.0563 0.0515 0.0440 
Final wR2 indexes 
[all data]  
0.1054 0.1241 0.1164 0.1326 0.1234 0.1281 0.1063 
 
Solid-State NMR Studies 
Solid-state 13C NMR was used for initial identification/screening of the bulk sample; 
successful formation of a cocrystal was clearly indicated by a 13C spectrum that was distinct 
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from the starting materials (see SI figures S12 to S18 for individual comparisons of spectra of 
starting and final materials). The value of characterizing the bulk sample is highlighted by a 
number of syntheses in which minority crystals of starting materials were selected for single 
crystal diffraction, suggesting, incorrectly, that cocrystals had not been formed. 
 
The 13C solid-state NMR spectra of the materials synthesised are shown in figure 4. In most 
cases the spectra indicate a phase-pure material distinct from the starting materials. 
Additional peaks corresponding to unreacted coformer ar  clearly identified in the case of 
INH-4HCA, and more tentatively, in the sample of INH-2HCA (see figures S11 and S13 
respectively in the supplementary information). This is consistent with the PXRD, Figure 2, 
which showed an additional crystalline component in the case of INH-2HCA, while the 
additional peaks in the INH-4HCA NMR spectrum may be associated with the background 
feature in the powder diffractogram. There is no evid nce of significant fractions of 
amorphous materials, suggesting that the background bserved in the PXRD patterns is due 
to poorly crystalline fractions. The 13C NMR spectra provide a direct, visual means of 
assessing the formation of a new crystalline form and its phase purity. Spectral overlap means 
that 2D NMR data would be required to fully assign the spectra. This is not, however, 
necessary for the spectra to be used as fingerprints of the different solid forms studied, and so 
is outside the scope of the current publication. There is one interesting correlation between 
hydrogen bonding patterns and the 13C chemical shifts. Although the carbonyl of the INH 
hydrazide (acceptor G in Table 1) does not strongly participate in hydrogen bonding itself, its 
shift ranges between 159 to 161 ppm for structures where the acid OH is hydrogen bonded to 
the NH2 of hydrazide, but varies between 164 to 172 ppm when the acid OH is hydrogen 
bonded to the pyridine nitrogen. This presumably reflects the correlations between hydrogen 
bonding patterns observed in a synthon analysis (Table S1), where different patterns of 
hydrogen bonding are observed depending on the hydrogen bonding behaviour of the acid 
OH.  Note that calculated 15N shieldings were also able to discriminate between th se overall 
arrangements, with the NH shift of the hydrazide being most distinctive (see figure S20 in 
SI). Unfortunately, the extremely long 1H relaxation times of these system precluded 
obtaining experimental 15N spectra. Figure S19 of the SI shows 1H spectra obtained under 
fast magic-angle spinning. These spectra present some unusual features which are still under 





Figure 4: 13C CP/MAS spectra of the isoniazid cocrystals studied. Markers indicate predicted 
positions of peaks from DFT calculations starting from the single-crystal structures. Two sets 
of carbonyl resonances are highlighted: the cinnamic acid carbon (C9, turquoise) and the 
hydrazide carbon (C16, purple); see Fig. 3 for the numbering scheme. The vertical dashed 
line illustrates the high vs. low frequency separation of the C16 resonance depending on 
whether the cinnamic acid hydrogen (donor I ) is hydrogen bonded to acceptor F (cocrystal 
name in italics) or acceptor D of Table 1. Asterisks mark spinning sidebands, × corresponds 
to an impurity phase of the coformer. Additional peaks in spectrum of INH-2HCA, probably 




Isoniazid (INH) readily forms cocrystals with hydroxyl derivatives of cinnamic acids due to 
the complementary nature of the functional groups of INH and the chosen coformers. The 
three previously unknown cocrystal forms, plus a new polymorph were characterized by 
solid-state NMR, DSC, PXRD and their structures were determined by single-crystal XRD. 
The tendency of 3,4-dihydroxycinnamic acid to form polymorphs when cocrystallized with 
isoniazid was confirmed by the production of an additional polymorph (Form 4). The new 
form differs only in the conformation of 34DHCA by 180o rotation around the Ph–C=C bond 
with all other same parameters. 13C solid-state NMR is observed to play a valuable 
complementary role to PXRD in evaluating phase purity and the extent of cocrystal 
formation. Individual 13C chemical shifts were observed to distinguish betwe n alternative 
hydrogen bonding arrangements, which may provide valuable constraints in cases where the 
structure needs to be solved from PXRD data.[48] Synthesized cocrystals might be able to 
replace INH in the existing FDCs used to treat TB by expected mitigation of degradation of 
RIF and INH from hydrazone formation by masking the k y hydrazide group through 
cocrystallization. This study also renders an opportunity to combine INH with an antioxidant 
in a single tablet. 
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• Three novel cocrystal  and a new polymorph cocrystal of isoniazid are synthesized  
• All structures are charaterized by IR, DSC, PXRD, 13C Solid-State NMR and Single crystal 
XRD techniques 
• Three prviously known cocrystals of isoniazid are synthesized and characterised 
• 13C solid-state NMR is observed to play a valuable complementary role to PXRD in 
evaluating phase purity and the extent of cocrystal formation 
• 13C chemical shifts are observed to distinguish between alternative hydrogen bonding 
arrangements  
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